NEPHROSANT

NephroSant is a biotechnology company that develops pioneering diagnostic tools for the early detection of risk of kidney disease or injury and long-term monitoring of kidney health. NephroSant is a diagnostic platform company dedicated to understanding the spectrum of kidney health. Utilization of NephroSant's testing tools help identify the risk of transplant rejection, support kidney health and detect the risk of kidney rejection earlier. QSant is a noninvasive, urine-based test that supports early detection of kidney rejection risk by providing an actionable, individual risk score that can empower clinicians to personalize care.

Primary location: Brisbane United States